(a) For purposes of this Section, the following terms shall have the following meanings:

1. (1) Accreditation body means an impartial non-profit organization that operates in conformance with the International Organization for Standardization (ISO) / International Electrotechnical Commission (IEC) standard 17011 and is a signatory to the International Laboratory Accreditation Cooperation (ILAC) Mutual Recognition Arrangement (MRA) for Testing.
2. (2) Scope of accreditation means a document issued by an accreditation body that attests to the laboratory’s competence to carry out specific testing and analysis.
3. (3) Testing laboratory means an independent, third-party laboratory, contracted by a cannabinoid hemp processor to test cannabinoid hemp products.

(b) To be recognized as a testing laboratory for purposes of testing cannabinoid hemp products as required by this Part, a laboratory must either be approved to test medical marijuana pursuant to section 55-2.15 of Title 10 of the Official Compilation of Codes, Rules and Regulations of the State of New York, article 6 of the Cannabis Law, or meet all of the following minimum requirements:

1. (1) maintain ISO/IEC 17025 accreditation for the premises and for the testing of one or more of the following:

   1. (i) cannabinoids;
   2. (ii) heavy metals;
   3. (iii) microbial impurities;
   4. (iv) mycotoxins;
   5. (v) residual pesticides;
   6. (vi) residual solvents and processing chemicals; or
   7. (vii) if tested, terpenoids.
2. (2) maintain a valid scope of accreditation, issued by an accreditation body, that attests to the laboratory’s competence to perform testing of one or more analytes listed in paragraph (1) of this subdivision.
3. (3) maintain method validation reports for all testing performed; and
4. (4) maintain standard operating procedures for the sampling of cannabinoid hemp products.

(e) The office shall have the ability to impose additional testing requirements including but not limited to, testing for additional analytes, setting stricter contaminant limits and mandating the use of specific sampling methodologies per lot or batch manufactured.

1. (1) Abamectin, 300 parts per billion.
2. (2) Acephate, 3,000 parts per billion.
3. (3) Acequinocyl, 2,000 parts per billion.
4. (4) Acetamiprid, 3,000 parts per billion.
5. (5) Aldicarb, 100 parts per billion.
6. (6) Azoxystrobin, 3,000 parts per billion.
7. (7) Bifenazate, 3,000 parts per billion.
8. (8) Bifenthrin, 500 parts per billion.
9. (9) Boscalid, 3,000 parts per billion.
10. (10) Captan, 3,000 parts per billion.
11. (11) Carbaryl, 500 parts per billion.
12. (12) Carbofuran, 100 parts per billion.
13. (13) Chlorantraniliprole, 3,000 parts per billion.
14. (14) Chlordane, 100 parts per billion.
15. (15) Chlorfenapyr, 100 parts per billion.
16. (16) Chlormequat chloride, 3,000 parts per billion.
17. (17) Chlorpyrifos, 100 parts per billion.
18. (18) Clofentezine, 500 parts per billion.
19. (19) Coumaphos, 100 parts per billion.
20. (20) Cyfluthrin, 1,000 parts per billion.
21. (21) Cypermethrin, 1,000 parts per billion.
22. (22) Daminozide, 100 parts per billion.
23. (23) DDVP (Dichlorvos), 100 parts per billion.
24. (24) Diazinon, 200 parts per billion.
25. (25) Dimethoate, 100 parts per billion.
26. (26) Dimethomorph, 3,000 parts per billion.
27. (27) Ethoprop(hos), 100 parts per billion.
28. (28) Etofenprox, 100 parts per billion.
29. (29) Etoxazole, 1,500 parts per billion.
30. (30) Fenhexamid, 3,000 parts per billion.
31. (31) Fenoxycarb, 100 parts per billion.
32. (32) Fenpyroximate, 2,000 parts per billion.
33. (33) Fipronil, 100 parts per billion.
34. (34) Flonicamid, 2,000 parts per billion.
35. (35) Fludioxonil, 3,000 parts per billion.
36. (36) Hexythiazox, 2,000 parts per billion.
37. (37) Imazalil, 100 parts per billion.
38. (38) Imidacloprid, 3,000 parts per billion.
39. (39) Kresoxim-methyl, 1,000 parts per billion.
40. (40) Malathion, 2,000 parts per billion.
41. (41) Metalaxyl, 3,000 parts per billion.
42. (42) Methiocarb, 100 parts per billion.
43. (43) Methomyl, 100 parts per billion.
44. (44) Methyl parathion, 100 parts per billion.
45. (45) Mevinphos, 100 parts per billion.
46. (46) Myclobutanil, 3,000 parts per billion.
47. (47) Naled, 500 parts per billion.
48. (48) Oxamyl, 500 parts per billion.
49. (49) Paclobutrazol, 100 parts per billion.
50. (50) Pentachloronitrobenzene, 200 parts per billion.
51. (51) Permethrin, 1,000 parts per billion.
52. (52) Phosmet, 200 parts per billion.
53. (53) Piperonyl butoxide, 3,000 parts per billion.
54. (54) Prallethrin, 400 parts per billion.
55. (55) Propiconazole, 1,000 parts per billion.
56. (56) Propoxur, 100 parts per billion.
57. (57) Pyrethrins, 1,000 parts per billion.
58. (58) Pyridaben, 3,000 parts per billion.
59. (59) Spinetoram, 3,000 parts per billion.
60. (60) Spinosad A & D, 3,000 parts per billion.
61. (61) Spiromesifen, 3,000 parts per billion.
62. (62) Spirotetramat, 3,000 parts per billion.
63. (63) Spiroxamine, 100 parts per billion.
64. (64) Tebuconazole, 1,000 parts per billion.
65. (65) Thiacloprid, 100 parts per billion.
66. (66) Thiamethoxam, 1,000 parts per billion.
67. (67) Trifloxystrobin, 3,000 parts per billion.

(f) Pesticide limits.

The following list of contaminants does not constitute authorization to use or apply any of the following during hemp cultivation or processing. If a pesticide is identified that is not listed here, the method limit of quantitation should be considered the maximum residue level for the unlisted pesticide:

(g) Residual solvent limits.

1. (1) 1,2-Dichloroethane, 5 parts per million.
2. (2) 1,1-Dichloroethene, 8 parts per million.
3. (3) Acetone, 5,000 parts per million.
4. (4) Acetonitrile, 410 parts per million.
5. (5) Benzene, 2 parts per million.
6. (6) Butane, 2,000 parts per million.
7. (7) Chloroform, 60 parts per million.
8. (8) Ethanol, 5,000 parts per million.
9. (9) Ethyl Acetate, 5,000 parts per million.
10. (10) Ethyl Ether, 5,000 parts per million.
11. (11) Ethylene Oxide, 5 parts per million.
12. (12) Heptane, 5,000 parts per million.
13. (13) Hexane, 290 parts per million.
14. (14) Isopropyl Alcohol, 5,000 parts per million.
15. (15) Methanol, 3,000 parts per million.
16. (16) Methylene Chloride, 600 parts per million.
17. (17) Pentane, 5,000 parts per million.
18. (18) Propane, 5,000 parts per million.
19. (19) Toluene, 890 parts per million.
20. (20) Trichloroethylene (1,1,2-Trichloroethene), 80 parts per million.
21. (21) Xylenes, Total (ortho-, meta-, para-), 2170 parts per million.

(h) Metals limits.

1. (1) Cadmium, 0.5 micrograms/gram for cannabinoid hemp products intended for ingestion. 0.2 micrograms/gram for cannabinoid hemp products intended for inhalation.
2. (2) Lead, 1.0 micrograms/gram for cannabinoid hemp products intended for ingestion. 0.5 micrograms/gram for cannabinoid hemp products intended for inhalation.
3. (3) Arsenic, 1.5 micrograms/gram for cannabinoid hemp products intended for ingestion. 0.2 micrograms/gram for cannabinoid hemp products intended for inhalation.
4. (4) Mercury, 1.5 micrograms/gram for cannabinoid hemp products intended for ingestion. 0.1 micrograms/gram for cannabinoid hemp products intended for inhalation.

(i) Biological limits.

1. (1) Shiga toxin-producing Escherichia coli (STEC E. coli) and other pathogenic E. coli, none present detected in 1 gram.
2. (2) Salmonella, none present.
3. (3) Total plate count for aerobic bacteria, <104 CFUs/gram.
4. (4) Total yeast and mold, <103 CFUs/gram.

(j) Mycotoxin limits.

1. (1) Total Aflatoxin (B1, B2, G1, G2), 20 parts per billion.

2. (2) Ochratoxin A, 20 parts per billion.

   (k) Cannabinoid limits.

   The total Δ9-Tetrahydrocannabinol concentration for cannabinoid hemp products shall not exceed 3/10ths of a percent (0.3 percent). If a cannabinoid hemp product fails, the processor may elect to re-extract the failing batch to reduce the total Δ9-Tetrahydrocannabinol of the batch to not more than 3/10ths of a percent (0.3 percent) total Δ9-Tetrahydrocannabinol. If the re-extracted batch still exceeds the 3/10ths of a percent (0.3 percent) total Δ9-Tetrahydrocannabinol the processor shall destroy the batch in compliance with section 114.7(d) of this Part.